Galmed Pharmaceuticals
GLMD
#9872
Rank
NZ$7.49 M
Marketcap
$4.97
Share price
-3.57%
Change (1 day)
-35.66%
Change (1 year)

EPS for Galmed Pharmaceuticals (GLMD)

EPS in 2023 (TTM): -$11.15

According to Galmed Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is -$11.20. In 2022 the company made an earnings per share (EPS) of -$17.70 an increase over its 2021 EPS that were of -$33.15.

EPS history for Galmed Pharmaceuticals from 2013 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$11.15-36.98%
2022-$17.70-46.62%
2021-$33.15-2.22%
2020-$33.9039.18%
2019-$24.3670.18%
2018-$14.32-41.84%
2017-$24.61-34.23%
2016-$37.4256.84%
2015-$23.869.2%
2014-$21.85-53.43%
2013-$46.92

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-$2.16-80.72%๐Ÿ‡บ๐Ÿ‡ธ USA
-$6.73-39.91%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
-$1.26-88.79%๐Ÿ‡บ๐Ÿ‡ธ USA
-$3.95-64.72%๐Ÿ‡บ๐Ÿ‡ธ USA